Matches in Wikidata for { <http://www.wikidata.org/entity/Q58479821> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q58479821 description "article scientifique publié en 2012" @default.
- Q58479821 description "artículu científicu espublizáu en febreru de 2012" @default.
- Q58479821 description "im Februar 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58479821 description "scientific article published on 24 February 2012" @default.
- Q58479821 description "wetenschappelijk artikel" @default.
- Q58479821 description "наукова стаття, опублікована в травні 2012" @default.
- Q58479821 name "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 name "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 type Item @default.
- Q58479821 label "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 label "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 prefLabel "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 prefLabel "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 P1433 Q58479821-8973A22C-DDED-418E-AC8A-0D1D92177541 @default.
- Q58479821 P1476 Q58479821-C7277BB8-929C-47E6-9FEF-1BCA1404C120 @default.
- Q58479821 P2093 Q58479821-23D66159-63EE-4FE8-8FE7-3FC860EE9907 @default.
- Q58479821 P2093 Q58479821-BEAD5984-52B6-4A07-84DD-EE3CFD1E7D73 @default.
- Q58479821 P2093 Q58479821-C43ADDA3-F71A-4BDD-8B69-7CE3BEDFB2B2 @default.
- Q58479821 P2093 Q58479821-D9760822-583E-402F-A606-69A6E1799744 @default.
- Q58479821 P304 Q58479821-9127AE35-6E25-468A-AF93-EB0AC715A238 @default.
- Q58479821 P31 Q58479821-4DDBE937-2281-4CA4-857C-9B50F9B98EFA @default.
- Q58479821 P356 Q58479821-643365E0-2AD3-496F-980D-590CCFA925C7 @default.
- Q58479821 P407 Q58479821-4D3D8F58-F191-4266-AFE2-71BE31BCD502 @default.
- Q58479821 P433 Q58479821-12746CE9-150B-4514-AF0A-48C3B1D9C7F7 @default.
- Q58479821 P478 Q58479821-4A8DE8D2-E286-4D32-8573-270C6E6D7E46 @default.
- Q58479821 P50 Q58479821-23D98417-D7E6-4AA5-8903-10EDDB147D9A @default.
- Q58479821 P50 Q58479821-53252577-648B-4A5A-9D1A-636FDC24BDB8 @default.
- Q58479821 P50 Q58479821-601013C8-D18E-4A28-9CD5-C5C7BC829328 @default.
- Q58479821 P577 Q58479821-5543CF02-353C-4A86-9FE9-2027DF584CCC @default.
- Q58479821 P698 Q58479821-5A10AA53-B957-477C-BBFF-A709830C76FD @default.
- Q58479821 P921 Q58479821-65F57230-6984-44CF-8402-26F27B583572 @default.
- Q58479821 P921 Q58479821-FA48EEC5-2165-4173-8F81-CA7D14E4BC5B @default.
- Q58479821 P921 Q58479821-c8743c58-4181-6747-51c3-bac02cfb2f4f @default.
- Q58479821 P356 J.IJPHARM.2012.02.025 @default.
- Q58479821 P698 22387278 @default.
- Q58479821 P1433 Q6051539 @default.
- Q58479821 P1476 "Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice" @default.
- Q58479821 P2093 "Daniel Scherman" @default.
- Q58479821 P2093 "Denis Brossard" @default.
- Q58479821 P2093 "Guy G Chabot" @default.
- Q58479821 P2093 "Philippe Arnaud" @default.
- Q58479821 P304 "452-459" @default.
- Q58479821 P31 Q13442814 @default.
- Q58479821 P356 "10.1016/J.IJPHARM.2012.02.025" @default.
- Q58479821 P407 Q1860 @default.
- Q58479821 P433 "2" @default.
- Q58479821 P478 "427" @default.
- Q58479821 P50 Q56056849 @default.
- Q58479821 P50 Q60159281 @default.
- Q58479821 P50 Q99714469 @default.
- Q58479821 P577 "2012-02-24T00:00:00Z" @default.
- Q58479821 P698 "22387278" @default.
- Q58479821 P921 Q12078 @default.
- Q58479821 P921 Q418384 @default.
- Q58479821 P921 Q461809 @default.